OP-19A - Implication of Maternal Continuous Enrollment on Stillbirth Gestational Age Distributions and Maternal Characteristics in Medicaid Enrollees
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-19B - Feasibility of Using Healthcare Utilization Data to Identify Neurodevelopmental Disorders for Transgenerational Pharmacoepidemiology
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-19D - Validating an Optimized Live Birth Gestational Age Algorithm in a Nationwide Medicaid Sample and Quantifying the Misclassification of Exposure Due to Estimated Gestational Age
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-19E - Statistical Power for Use of Tree-based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
11:45 AM - 1:30 PM US Eastern Time
OP-19F - Use of Tree-based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use: A Propensity Score Matched Case Study
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
11:45 PM - 1:30 PM US Eastern Time
OP-19C - Fertility Rates in Women with Psoriasis and Psoriatic Arthritis: A Population-based Cohort Study
Location: OP-19
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18A - Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-infant Linkage Table
Location: OP-18
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18B - Increasing Prescriptions of Misoprostol Dispensed Before Delivery in Belgium (2003-2017): Evidence from Healthcare Administrative Database
Location: OP-18
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18C - Effects of Gadolinium-enhanced MRI Exposure During Pregnancy on Neonatal Intensive Care Unit Admission
Location: OP-18
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18D - Proton Pump Inhibitors in Pregnancy and Risk of Preeclampsia: A Nationwide Cohort Study of 1.9 Million Pregnancies
Location: OP-18
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18E - Validity of ICD-10 Z3A Codes for Estimating Date of Last Menstrual Period
Location: OP-18
Pregnancy and Lactation
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-18F - COVID-19 Pharmacotherapy During Pregnancy: International Registry of Coronavirus Exposure in Pregnancy (IRCEP)
Location: OP-18
Pregnancy and Lactation
Tuesday, Aug 24th
10:00 AM - 11:30 AM US Eastern Time
WS-07 - How to Emulate a Target Trial to Study the Effects of Treatments for and During Pregnancy
Location: WS-07
Pregnancy and Lactation
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP14A - Use of Interrupted Time-series Analysis to Characterize Antibiotic Prescription Fills Across Pregnancy – a Norwegian Nation-wide Cohort Study
Location: SP14
Pregnancy and Lactation
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP14E - Risky Drug Prescribing in 1.8 Million French Pregnant Women: A Nationwide Study Based on Two Risk Classification Systems
Location: SP14
Pregnancy and Lactation
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP14G - Women of Reproductive Age in the COVID-19 Active Research Experience (CARE) Registry
Location: SP14
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16A - First Trimester Exposure to Buprenorphine Compared to Methadone for Treatment of Opioid Use Disorders and the Risk of Congenital Malformations
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16B - Characteristics of Initial Postpartum Opioid Prescribing and Risks of Serious Opioid-related Events After Cesarean Delivery
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16C - Prescription Opioid Type and the Risk of Neonatal Opioid Withdrawal Syndrome
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16D - Benzodiazepine Use in the First Trimester and Risk of Congenital Malformations: A Nationwide Cohort Study in South Korea
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16E - Comparative Safety of In-utero Exposure to Buprenorphine Combined with Naloxone versus Buprenorphine Monoproduct with Respect to Congenital Malformations
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-16F - Prenatal Analgesic Opioid Exposure and Risk of ADHD in Childhood
Location: OP-16
Pregnancy and Lactation
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-21A - Prenatal Antiseizure Medication Exposure and Risk of Autism and Intellectual Disability. SCAN-AED: A Nordic Cohort Study
Location: OP-21
Pregnancy and Lactation
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-21B - The Comparative Safety of Antiseizure Medication Polytherapy versus Valproate in Pregnancy and Risk of Major Congenital Malformations
Location: OP-21
Pregnancy and Lactation
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-21C - Antidepressant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children
Location: OP-21
Pregnancy and Lactation
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-21D - The Impact of In-utero Antipsychotic Drug Exposure on Congenital Malformations: An International Cohort Study
Location: OP-21
Pregnancy and Lactation
Wednesday, Aug 25th
3:00 PM - 4:30 PM US Eastern Time
OP-21F - The Impact of In-utero Antipsychotic Exposure on Neurodevelopmental Disorders in Children
Location: OP-21
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17A - Characteristics and Outcomes of Pregnancies in Women with Heart Failure: A Retrospective Cohort Study in the Sentinel System
Location: OP-17
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17B - Metformin and Risk of Adverse Pregnancy Outcomes Among Pregnant Women with Gestation Diabetes in the United Kingdom: A Population-based Cohort Study
Location: OP-17
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17C - The Role of Propensity Score Matching in Claims-based Studies for Achieving Comparability in hba1c Levels Between Treatments in Pregnant Women with Type 2 Diabetes
Location: OP-17
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17D - Balance of Unmeasured Covariates After Propensity Score Matching Based on Measurable Covariates in Perinatal Pharmacoepidemiologic Studies
Location: OP-17
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17E - Development and Validation of ICD-10 Claims-based Algorithms for Pregnancy and Infant Outcomes
Location: OP-17
Pregnancy and Lactation
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-17F - Metformin versus Insulin in Early Pregnancy and Risk of Congenital Malformations
